DexCom Inc (DXCM)
127.42
-2.68
(-2.06%)
USD |
NASDAQ |
May 08, 16:00
127.47
+0.05
(+0.04%)
After-Hours: 20:00
DexCom Cash from Investing (Quarterly): 74.80M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 74.80M |
| December 31, 2023 | 414.90M |
| September 30, 2023 | -179.50M |
| June 30, 2023 | -555.90M |
| March 31, 2023 | -186.70M |
| December 31, 2022 | -194.10M |
| September 30, 2022 | 229.30M |
| June 30, 2022 | -144.90M |
| March 31, 2022 | -411.80M |
| December 31, 2021 | -496.10M |
| September 30, 2021 | 29.00M |
| June 30, 2021 | 363.20M |
| March 31, 2021 | -112.20M |
| December 31, 2020 | -24.00M |
| September 30, 2020 | -9.30M |
| June 30, 2020 | -1.115B |
| March 31, 2020 | 130.60M |
| December 31, 2019 | -94.30M |
| September 30, 2019 | -412.80M |
| June 30, 2019 | -639.40M |
| March 31, 2019 | 131.30M |
| December 31, 2018 | 30.90M |
| September 30, 2018 | 4.60M |
| June 30, 2018 | -159.90M |
| March 31, 2018 | -15.40M |
| Date | Value |
|---|---|
| December 31, 2017 | -1.10M |
| September 30, 2017 | -36.60M |
| June 30, 2017 | -85.30M |
| March 31, 2017 | -21.40M |
| December 31, 2016 | -17.30M |
| September 30, 2016 | -17.80M |
| June 30, 2016 | -9.60M |
| March 31, 2016 | -11.20M |
| December 31, 2015 | -12.70M |
| September 30, 2015 | -5.70M |
| June 30, 2015 | -7.20M |
| March 31, 2015 | -25.90M |
| December 31, 2014 | -4.70M |
| September 30, 2014 | -3.80M |
| June 30, 2014 | -4.00M |
| March 31, 2014 | -4.30M |
| December 31, 2013 | 0.50M |
| September 30, 2013 | 1.70M |
| June 30, 2013 | 6.10M |
| March 31, 2013 | 12.60M |
| December 31, 2012 | 6.60M |
| September 30, 2012 | 3.50M |
| June 30, 2012 | 6.60M |
| March 31, 2012 | 11.70M |
| December 31, 2011 | -3.475M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.115B
Minimum
Jun 2020
414.90M
Maximum
Dec 2023
-166.72M
Average
-128.55M
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -425.00M |
| Edwards Lifesciences Corp | 63.10M |
| Boston Scientific Corp | -285.00M |
| Cardinal Health Inc | -1.847B |
| Insulet Corp | -31.60M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 209.20M |
| Cash from Financing (Quarterly) | 4.70M |
| Free Cash Flow | 583.50M |
| Free Cash Flow Per Share (Quarterly) | 0.3655 |
| Free Cash Flow to Equity (Quarterly) | 150.50M |
| Free Cash Flow to Firm (Quarterly) | 152.30M |
| Free Cash Flow Yield | 1.08% |